Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

KINFix - A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Brain tumor biomarkers for research, clinics, and registries - The 2021 Brain Tumor Epidemiology Consortium meeting report

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Expression of the stem cell marker CD133 in malignant meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. VEGF-A mRNA measurement in meningiomas using a new simplified approach: branched DNA and chemiluminescence

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic Accuracy and Clinical Impact of [ 18F]FET PET in Childhood CNS tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Brain tumor biomarkers for research, clinics, and registries - The 2021 Brain Tumor Epidemiology Consortium meeting report

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pathologic Characteristics of Pregnancy-Related Meningiomas

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: Individual Patient Data Meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Harald Stefanits
  • Michał Bieńkowski
  • Markus Galanski
  • Goran Mitulović
  • Thomas Ströbel
  • Ellen Gelpi
  • Teresa Ribalta
  • Helle Broholm
  • Christian Hartmann
  • Johan M Kros
  • Matthias Preusser
  • Johannes A Hainfellner
View graph of relations

An optimal fixative should ideally combine the advantages of formalin fixation and freezing, allowing for good preservation of histology and molecular components, easy handling and storage, lack of toxicity, and low costs. Most of these criteria are fulfilled by ethanol-based solutions, and due to our good experience with the commercial RCL2 fixative, reflected by our published single-center trial, we initiated a multicenter ring trial. However, during its course, RCL2 was discontinued on the market. Therefore, we created our own agent, KINFix, composed of the same main constituents as RCL2, and employed it in our laboratory with similar results. Here we present our evaluation of the three fixatives formalin, RCL2, and KINFix from the perspective of histopathology as well as nucleic acid and protein analyses in comparison to fresh frozen tissues together with the multicenter ring trial data for RCL2. We observe that RCL2 and KINFix offer comparable histomorphology and superior template for molecular analyses than formalin. Moreover, KINFix as freely available fixative might overcome some of the difficulties related to the commercial agents. Therefore, we conclude that KINFix might be an attractive complement to formalin in tissue processing and advocate its use in neuropathological practice.

Original languageEnglish
JournalClinical Neuropathology
Volume35
Pages (from-to)3-12
ISSN0722-5091
DOIs
Publication statusPublished - 2016

ID: 45866778